menu search

BAX / Earnings Preview: Baxter International (BAX) Q2 Earnings Expected to Decline

Earnings Preview: Baxter International (BAX) Q2 Earnings Expected to Decline
Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read More
Posted: Jul 20 2023, 11:26
Author Name: Zacks Investment Research
Views: 110248

BAX News  

Baxter (BAX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

By Zacks Investment Research
November 3, 2023

Baxter (BAX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to com more_horizontal

Baxter International beats Q3 profit estimates on strong demand for medical devices

By Reuters
November 2, 2023

Baxter International beats Q3 profit estimates on strong demand for medical devices

Baxter International on Thursday beat Wall Street expectations for third-quarter revenue and profit, as a recovery in surgical procedure volumes after more_horizontal

BAX vs. SYK: Which Stock Is the Better Value Option?

By Zacks Investment Research
October 30, 2023

BAX vs. SYK: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Products sector might want to consider either Baxter International (BAX) or Stryker (SYK). But which of more_horizontal

Baxter (BAX) to Report Q3 Earnings: Is a Beat in Store?

By Zacks Investment Research
October 30, 2023

Baxter (BAX) to Report Q3 Earnings: Is a Beat in Store?

Baxter's (BAX) third-quarter results are likely to reflect growth in elective surgical procedures, offset by currency movement. Hillrom's products mig more_horizontal

Baxter's (BAX) New Launch to Enable Earlier Treatment of Eye

By Zacks Investment Research
October 18, 2023

Baxter's (BAX) New Launch to Enable Earlier Treatment of Eye

Baxter's (BAX) latest offering is likely to enable a more digitally-connected primary care examination and support faster diagnosis for earlier treatm more_horizontal

What other industries could weight loss drugs disrupt?

By CNBC Television
October 11, 2023

What other industries could weight loss drugs disrupt?

Jared Holz, Mizuho health care sector strategist, joins the ‘Fast Money' traders to discuss Novo Nordisj's kidney trial outcomes and the impact of w more_horizontal

Why Investors Punished Baxter International Stock Today

By The Motley Fool
October 11, 2023

Why Investors Punished Baxter International Stock Today

A drug made by a rival tested well in a clinical trial for kidney disease. That treatment is currently a very hot product, but for different indicatio more_horizontal

The 3 Widest Competitive Moats on Wall Street

By Zacks Investment Research
October 11, 2023

The 3 Widest Competitive Moats on Wall Street

Competitive moats symbolize a company's sustainable advantage, protecting it from competitors and external threats. Three standout examples illustrate more_horizontal


Search within

Pages Search Results: